Cellectis (CLLS) Receivables (2013 - 2026)
Cellectis' (CLLS) quarterly Receivables came in at $12.7 million in Q1 2026, down 44.56% year-on-year from $23.0 million in Q1 2025, and down 42.58% quarter-over-quarter from $22.2 million in Q4 2025.
Cellectis (CLLS) Receivables (2013 - 2026) Analysis & Trends
Cellectis' Receivables history runs 14 years deep, the most recent figure standing at $12.7 million for Q1 2026.
- On a quarterly basis, Receivables fell 44.56% year-over-year to $12.7 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 44.56% decrease from a year earlier, with the FY2025 full-year figure at $22.2 million, up 4.53% from the prior year.
- Receivables fell to $12.7 million in Q1 2026 per CLLS's latest filing, from $22.2 million in the prior quarter.
- Across five years, Receivables topped out at $39.1 million in Q1 2024 and bottomed at $12.7 million in Q1 2026.
- The 5-year median for Receivables is $21.5 million (2023), against an average of $22.1 million.
- Across the five-year window, Receivables slumped 48.52% in 2022 and soared 102.1% in 2024, its largest moves.
- Year by year, Receivables stood at $15.3 million in 2022, then jumped by 40.61% to $21.5 million in 2023, then decreased by 1.09% to $21.2 million in 2024, then gained by 4.53% to $22.2 million in 2025, then sank by 42.58% to $12.7 million in 2026.
- Per Business Quant, the three latest CLLS Receivables figures stand at $12.7 million (Q1 2026), $22.2 million (Q4 2025), and $24.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 12.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.75 Mn |
| Dec 31, 2025 | 22.20 Mn |
| Sep 30, 2025 | 24.47 Mn |
| Jun 30, 2025 | 25.16 Mn |
| Mar 31, 2025 | 22.99 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 26.84 Mn |
| Jun 30, 2024 | 24.70 Mn |
| Mar 31, 2024 | 39.14 Mn |
| Dec 31, 2023 | 21.47 Mn |
| Sep 30, 2023 | 20.65 Mn |
| Jun 30, 2023 | 19.91 Mn |
| Mar 31, 2023 | 19.37 Mn |
| Dec 31, 2022 | 15.27 Mn |
| Sep 30, 2022 | 12.95 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 32.29 Mn |
| Dec 31, 2021 | 29.66 Mn |
| Sep 30, 2021 | 8.32 Mn |
| Jun 30, 2021 | 9.53 Mn |